Molecular and Image Diagnosis in Endometrial Cancer 2024
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 386
Special Issue Editor
2. College of Medicine, Chang Gung University, Taoyuan, Taiwan
Interests: molecular markers; prognosis; gynecologic cancers; treatment; screening
Special Issue Information
Dear Colleagues,
Over the past decade, we have seen rapid advancements in molecular biology and imaging technology, leading to significant improvements in the diagnosis of endometrial cancer. Integrating these innovative diagnostic techniques is increasingly informing the decision-making process in clinical practice, leading to better patient outcomes.
This Special Issue explores and discusses the latest innovations, trends, challenges, and solutions in molecular and image diagnosis in endometrial cancer. We are particularly interested in original research articles, systematic reviews that address these issues. Still, submissions are not limited to topics such as the discovery of new biomarkers, development of novel imaging techniques, clinical validation of molecular and imaging diagnostics, and integration of these tools into current management.
Prof. Dr. Tingchang Chang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endometrial cancer
- molecular classification
- imaging diagnosis
- biomarkers
- prognosis
- novel imaging techniques
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
